awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33389419-990B0A42-45D0-41D3-9FC7-F79C8C6DD5E1
Q33389419-990B0A42-45D0-41D3-9FC7-F79C8C6DD5E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33389419-990B0A42-45D0-41D3-9FC7-F79C8C6DD5E1
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.
P2860
Q33389419-990B0A42-45D0-41D3-9FC7-F79C8C6DD5E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33389419-990B0A42-45D0-41D3-9FC7-F79C8C6DD5E1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b723c57986c57824022f6bfe4ea26fa522838d73
P2860
Therapeutic goals in the treatment of Gaucher disease.